Association Between Systemic Inflammation Response Index and Slow Coronary Flow Phenomenon in Patients with Ischemia

Yang-Da Chen1, Zhi-Gao Wen1, Jun-Jie Long1

  • 1Department of Emergency Medicine, Shenzhen Luohu Hospital Group Luohu People's Hospital (The Third Affiliated Hospital of Shenzhen University), Shenzhen, People's Republic of China.

Insights

The Systemic Inflammation Response Index (SIRI) can help predict slow coronary flow phenomenon (SCFP) in patients with ischemia and no obstructive coronary arteries (INOCA). Higher SIRI levels are associated with SCFP, offering a potential new diagnostic tool.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Inflammation is central to slow coronary flow phenomenon (SCFP) pathogenesis.
  • SCFP complicates ischemia with no obstructive coronary arteries (INOCA) management.
  • Reliable predictors for SCFP in INOCA patients are needed.

Purpose of the Study:

  • To investigate the predictive value of the Systemic Inflammation Response Index (SIRI) for SCFP in INOCA patients.
  • To assess SIRI's potential as a biomarker for SCFP.

Main Methods:

  • 1422 INOCA patients were studied, with 89 diagnosed with SCFP.
  • Age- and sex-matched controls (n=178) with normal coronary flow were selected.
  • Plasma neutrophil, monocyte, and lymphocyte counts were used to calculate SIRI.

Main Results:

  • SCFP patients had higher BMI, smoking, and diabetes rates.
  • SIRI was significantly higher in the SCFP group (2.3±1.3 vs 1.8±1.3, p=0.002).
  • Multivariate analysis identified BMI and SIRI as independent predictors of SCFP; SIRI > 1.140 showed 87.6% sensitivity and 60.1% specificity.

Conclusions:

  • Elevated SIRI may help identify SCFP in INOCA patients.
  • SIRI demonstrates potential as a valuable predictor for SCFP.
  • SIRI offers improved predictive value over individual inflammatory cell counts.
Abstract